In a recent study, Short-course neoadjuvant in situ vaccination for murine melanoma, researchers compared the effectiveness of neoadjuvant radiotherapy and/or tumor vaccination. See more below and the full study here.
Amidst concerns of radiological terrorism, there are institutional initiatives to replace radionuclide sources with lower energy X-ray sources. As researchers transition, questions remain regarding whether the biological effects of gamma-rays may be recapitulated with...
Superficial radiation therapy treatment provides a non-surgical option for patients with basal cell carcinoma, squamous cell carcinoma, and keloid scarring. In this webcast, Dr. Colin Dicks, Radiation Oncologist from Just Skin in Australia, describes more about the...
In the recent publication, A scoping review of small animal image-guided radiotherapy research: Advances, impact and future opportunities in translational radiobiology, researchers examined published research using small animal irradiators, including SARRP. See more...
As new technologies increase the accuracy and clinical relevance of our delivery of radiotherapy to preclinical models of cancer, it becomes even more important that the preclinical models are also representative of the clinical scenario. There are limitations to...
Orthovoltage radiotherapy provides a cost effective treatment option for a wide range of conditions – offering a small footprint, simple planning, and easy patient positioning. This clinical education event highlighted the use of orthovoltage radiation for the...
In the recent study, Orthovoltage X-Rays Exhibit Increased Efficacy Compared with γ-Rays in Preclinical Irradiation, researchers found that a dose reduction is necessary for X-rays to achieve comparable biological effects. See more below and the original study here....
New Cross Hospital, based in Wolverhampton, England, recently announced the installation of the Xstrahl 200 radiotherapy system to treat skin cancer and gynecological cancers. More information is available online at the BBC. The hospital staff described how this...
Xstrahl is proud to connect investigators from diverse audiences – including academic institutions, research hospitals, CROs, biotech and pharmaceutical companies, and countless interdisciplinary teams – to inspire science and advance care with successful preclinical...
Contact Us